<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03456011</url>
  </required_header>
  <id_info>
    <org_study_id>OrthoDSC</org_study_id>
    <nct_id>NCT03456011</nct_id>
  </id_info>
  <brief_title>Battlefield Acupuncture With Sodium Hyaluronate Injections</brief_title>
  <official_title>Battlefield Acupuncture (BFA), an Adjunct Treatment During Sodium Hyaluronate Injections for Knee Osteoarthritis: A Prospective Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brooke Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brooke Army Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates pain relief and subsequent range of motion changes combining battlefield
      acupuncture with sodium hyaluronate vs local anesthetic and sodium hyaluronate
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sodium hyaluronate is FDA approved for knee osteoarthritis. It is a widely used treatment for
      this condition. This does provide immediate pain relief and is often used in conjunction with
      lidocaine and ropivacaine to both improve pain relief and treatment tolerance.

      battlefield acupuncture has been showing promise as an adjunct pain relief treatment option.
      If used during intra articular visco supplementation knee injections, this may provide pain
      relief and positive changes in range of motion without the need of local anesthetic being
      injected into the joint space.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 23, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>4 months</time_frame>
    <description>Pain Scale. zero to 100 mm line. point on line if severity of pain. Zero no pain, 100 worst pain imaginable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale</measure>
    <time_frame>4 months</time_frame>
    <description>Pain Scale. Number pain scale 0-10. Zero no pain, 10 worst pain imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KOOS</measure>
    <time_frame>4 months</time_frame>
    <description>Knee function scoring. Questionnaire, scoring zero to 100. 100 is no pain or issues, zero is worst possible score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KOOS Physical function short form</measure>
    <time_frame>4 months</time_frame>
    <description>Knee function scoring. Questionnaire, scoring zero to 100. 100 is no pain or issues, zero is worst possible score.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>BFA with Eufflexa injections</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BFA treatment before Sodium Hyaluronate injections.
Intervention: BFA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anesthetic with Eufflexa injections</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Receiving Standard of care determined by their provider
No interventions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Battlefield Acupuncture</intervention_name>
    <description>Battlefield Acupuncture gold semi permanent needles</description>
    <arm_group_label>BFA with Eufflexa injections</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of the BAMC Orthopaedic clinic

          -  Active duty, dependent and civilians

          -  Ages 18-65

          -  Diagnosed with knee osteoarthritis by their Orthopaedic provider

          -  Determined to be eligible for Sodium Hyaluronate injections by their Orthopaedic
             provider

        Exclusion Criteria:

          -  Patient without knee osteoarthritis diagnosis

          -  Patient requiring immediate surgery for their knee complaints

          -  Patients younger than 18 or older than 65

          -  Pregnant patients

          -  Patients without active pain

          -  Patients with history of knee arthroplasty

          -  Patients with auricular deformity which would affect BFA

          -  Patient with history of vasovagal secondary to needles or injections

          -  Patients with active infection at BFA treatment sites
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christopher Gomez, MPAS</last_name>
    <phone>210-916-3057</phone>
    <email>christopher.gomez11.mil@mail.mil</email>
  </overall_contact>
  <location>
    <facility>
      <name>BAMC</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Gomez, MPAS</last_name>
      <phone>210-916-3057</phone>
      <email>christopher.gomez11.mil@mail.mil</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2018</study_first_submitted>
  <study_first_submitted_qc>March 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brooke Army Medical Center</investigator_affiliation>
    <investigator_full_name>Christopher Gomez</investigator_full_name>
    <investigator_title>Orthopaedic PA Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will only be shared within study group to include primary investigator and associate investigators. General demographic information will be collected to include in study results</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

